To include your compound in the COVID-19 Resource Center, submit it here.

Replimune raises $55M in a series B round

Replimune Group Inc. (Woburn, Mass.) raised $55 million in a series B round led by Foresite Capital. Fellow new investors Bain Capital Life Sciences,

Read the full 242 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE